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a b s t r a c t
Objectives: A comprehensive overview of the ways control measures directed at carriers of multidrug-
resistant organisms (MDRO) affect daily life of carriers is lacking. In this systematic literature review,
we sought to explore how carriers experience being a carrier and how they experience being subjected to
control measures by looking at the impact on basic capabilities.
Methods: We searched Medline, Embase and PsychINFO until 26 May 2016 for studies addressing ex-
periences of MDRO carriers. Twenty-seven studies were included, addressing experiences with
methicillin-resistant Staphylococcus aureus (n ¼ 21), ESBL (n ¼ 1), multiple MDRO (n ¼ 4) and other
(n ¼ 1, not specified). We categorized reported experiences according to Nussbaum's capability approach.
Results: Carriage and control measures were found to interfere with quality of care, cause negative
emotions, limit interactions with loved ones, cause stigmatization, limit recreational activities and create
financial and professional insecurity. Further, carriers have difficulties with full comprehension of the
problem of antimicrobial resistance, thus affecting six out of ten basic capabilities.
Conclusions: Applying Nussbaum's capability approach visualizes an array of unintended consequences
of control measures. Carriers experience stigmatization, especially in healthcare settings, and have
limited understanding of their situation and the complexities of antimicrobial resistance. B. Rump, Clin
Microbiol Infect 2019;25:274
© 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Antimicrobial resistance (AMR) is a serious health threat asso-
ciated with a substantial financial burden and estimated mortality
rates as high as 23 000 deaths a year for the United States and
25 000 for the European Union [1,2]. Contact precaution measures
aim to minimize direct or indirect contact with carriers of
multidrug-resistant organisms (MDROs) or their environment.
They are widely installed to prevent (further) transmission of
MDROs into the healthcare setting [1e4]. Control measures vary by
country [1e4]. Further, the literature remains inconclusive on their
effectiveness [5].
Carriage and related control measures are reported to have
negative implications for the well-being of carriers in terms of
health-related outcomes such as anxiety, stress and depression
[6e9]. It might well be that there is more at stake for carriers when
it comes to their well-being. The capability approach is a way of
thinking about well-being in terms of the genuine freedom people
have to achieve the things they personally value in life [10e15].
In view of a capability approach, the well-being of people de-
pends not only on basic things like avoiding unnecessary morbidity
and mortality or being in good physical and mental health. It also
includes achieving more complex things like being able to connect
to other people, be of worth for others or take part in community
life [10e12] (Supplementary Table S1). Using the capability
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approach to look at experiences of carriers may therefore offer a
better understanding of what truly is at stake for carriers and what
we thus should be concerned about protecting when implementing
control measures [16].
In this review, we sought to explore the experience of being
MDRO carrier and being subjected to related control measures by
looking at its impact on capabilities.
Methods
This review is registered at the PROSPERO register
(CRD42016034055) and reported according to the PRISMA state-
ment [17].
Eligibility criteria
We conducted an integrative review (allowing for the combi-
nation of qualitative and quantitative evidence) of the published
literature to identify studies reporting on experiences of people
diagnosed with MDRO colonization or infection [18]. Studies
reporting on infection control measures (e.g. isolation) and studies
addressing health-related outcomes (e.g. mortality or length of
hospital stay) were screened full text and were included only if
MDRO experiences could be separately extracted. Provided that
original data were presented, all article types were included.
Information sources and search strategy
We searched Medline, Embase and PsycINFO databases (OvidSP
interface) for studies describing experiences of people diagnosed
with MDRO colonization or infection and published before 27 May
2016. We combined search terms addressing MDRO colonization or
infection with outcome-related search terms like ‘barriers,’ ‘expe-
rience’ and ‘satisfaction’ (Supplementary Table S2). MDRO was
defined according to Kluytmans-Vandenbergh et al. [3] including
methicillin-resistant Staphylococcus aureus (MRSA).
Study selection and data collection
Abstracts and full texts were screened by one reviewer (BR);
random subsets of 151 abstracts (10%) and 40 full texts (25%) were
independently screened by second reviewers (AT and MH).
Disagreement was resolved by consensus discussion. Studies with
promising titles but missing abstracts were included in the full text
screening. Reference lists of included studies were searched to
identify further studies. Data regarding study specifics and expe-
riences were extracted using an Excel-based standardized data
extraction form.
Quality assessment
The diverse representation of primary sourcesdtypical for
integrative reviewsdcomplicates quality assessment [18]. Quality
assessment was performed using two criteria: firstly relevance in
terms of addressing the full experience of carriage, and secondly
representativeness in terms of being detailed enough (coded on a
2-point scale, limited or high) [19].
Synthesis of results
The framework of ten capabilities as proposed by Nussbaum
[12] was used for categorization (Supplementary Table S1). All text
fragments representing experiences of carriers were labelled and
grouped into themes. Themes were then further categorized ac-
cording to the capabilities they represented.
Results
The search strategy yielded 1496 unique publications; 162 were
retained for full text screening. Twenty-eight publications, repre-
senting 27 studies, met the inclusion criteria (Fig. 1).
Thirteen studies scored high on relevance (addressing full ex-
periences of carriers), of which nine also scored high on repre-
sentativeness (in-depth studies). The remaining 14 studies, except
for one, scored low on both relevance and representativeness,
focusing mainly on quality of delivered hospital care (six studies)
and anxiety and depression (five studies) (Loveday H et al., ‘The
patient experience of the MRSA screening process and the impact
of a MRSA positive result: a qualitative study,’ paper presented at
the 2nd International Conference on Prevention and Infection
Control, ICPIC 2013; Mo Y, Tambyah PA, ‘Socioeconomic impact of
multiresistant nosocomial infectionsdpreliminary results of a
qualitative study,’ paper presented at the 3rd International Con-
ference on Prevention and Infection Control, ICPIC 2015) [20e45].
Supplementary Table S3 lists the characteristics and quality
assessment of all included studies.
In terms of heterogeneity, studies were mainly set in the United
States (7/27), Sweden (6/27) and the United Kingdom (5/27), tar-
getingmainly the hospital setting (20/27) andhandlingmostlyMRSA
(21/27) or several MDROs (extended-spectrum b-lactamase (ESBL),
vancomycin-resistant enterococci and MRSA) (4/27); one study
concerned ESBL and one did not specify the MDRO. Types of control
measures were poorly specified. Quantitative (11/27) and qualitative
(11/27) studies were equally represented (Supplementary Table S3).
A total of 277 text fragments were extracted. Eighty-seven
percent (242/277) concerned negative experiences, 1% (4/277)
concerned positive experiences and 12% (31/277) concerned
neutral or mixed experiences (Supplementary Table S4). Impact per
capability was supported by a minimum of four and a maximum of
20 studies (Supplementary Table S5). Although aim and design
varied, results were consistent; any inconsistency found in the data
is mentioned in the text.
Six different capabilities were affected: bodily health (capability
2), emotion (capability 5), practical reason (capability 6), affiliation,
being able to laugh, play and to enjoy recreational activities (capa-
bility 9) and having control over one's environments (capability 10).
Impact on capabilities 1, 3, 4 and 8 was not observed (Fig. 2).
Bodily health (capability 2)
The capability ‘bodily health’ concerns being able to achieve good
health and remain healthy. It was addressed in 20 of 27 studies (Mo
Y, Tambyah PA, ‘Socioeconomic impact of multiresistant nosocomial
infections’) [20,24,25,27e33,35e38,40e42,44,45]. None of these
studies reports a lack of essential elements of healthcare, suggesting
that basic health needs are not at stake. However, carriers have
concerns about their treatment and feel they do not get access to
patient care on the same terms as noninfected patients
[20,27e29,36,37,39,42]. They perceive delays in care and effects on
length of hospital stay [28,30,38,40,41], and they describe time-
consuming trips to the infection clinic [31]. Carriage interferes
with rehabilitation [29,30,44]. Carriers also reported positive aspects
[34,36,37,40]: isolation ‘enabled them to sleep’ [37] and ‘helped their
adjustment to the injury’ [40]. Some carriers only seek healthcare
when absolutely necessary [31]. Three studies report only minor
interferences with treatment and little differences in perception of
care (Mo Y, Tambyah PA, ‘Socioeconomic impact of multiresistant
nosocomial infections’) [24,25]. Carriers are poorly informed or are
provided with information that fails to meet their needs [31,32,40].
They are left with a feeling of still wanting more information [32];
further, they are uncertain about their carriage status [31,40].
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Emotion (capability 5)
The capability of emotion relates to how a person's emotional
development canbeaffectedbyanxiety, fearor traumatic events such
as abuse or neglect, and how this interferes with being able to
experience the appropriate emotion for a situation. Carriage does not
affect this capability in terms of experiencing the appropriate emo-
tions, but 17 of 27 studies report on how the situation triggers certain
emotions that carriers presumably would prefer not to experience
(Loveday H et al., ‘The patient experience of the MRSA screening
process’) [20e23,25,26,28,29,33,35,37,40,41,43e45]. Lindberg et al.
[33] summarizes the experience as ‘invaded, unsecure and alone’ and
Skyman et al. [40] as ‘violated, unclean and scared.’ Isolation is re-
ported to beunpleasant and stressful [25,28,33,45]. Carriers placed in
hospital isolation score higher on depression [21,22,35,41,44].
Andersson et al. [20], Catalano et al. [21], Day et al. [22], Soon et al.
[41], Kennedy and Hamilton [29], Hartmann [28], Tarzi et al. [43] and
Wiklund et al. [45] also report higher scores on anxiety and remain
inconclusive on anger; Day et al. [22] and Donaldson et al. [23],
however, report no differences. Emotional reaction to initial diag-
nosis ismostly described as ‘shocking’or ‘traumatic’ (LovedayHet al.,
‘The patient experience of the MRSA screening process’)
[20,26,40,45], but indifference is also reported [20].
Practical reason (capability 6)
The capability of practical reason is understood as being able to
form a conception of the good and to engage in critical reflection
about the planning of one's life. The capability also requires having
a basic understanding of one's situation and being able to reflect on
it. It appears that carriers have difficulties with comprehension: 12
of 27 studies show they have limited understanding of their situ-
ation (Mo Y, Tambyah PA, ‘Socioeconomic impact of multiresistant
nosocomial infections’) [20,27,28,31,33,36e38,40,44,45]. This goes
beyond a lack of knowledgedas described in capability 2dand
concerns conceptualizing what it means to be a carrier. Few carriers
have a complete understanding of transmission and the reasons for
control measures (Mo Y, Tambyah PA, ‘Socioeconomic impact of
multiresistant nosocomial infections’) [28,36e38,45]. Many feel
uncertain [28,33]. ‘The lack of outwards signs [of infection] makes
the experience confusing and surreal’ [44]. Newton et al. [37]
report, ‘MRSA was perceived as not serious by half, whereas
others thought it was more serious.’
Some carriers question the reasonableness of MDRO control
measures: MRSA is called an ‘overstated problem’ [20], and strict
isolation practices are ‘considered redundant’ because ‘MRSA is out
of control’ [44]. Others feel that ‘certain rights and privileges have
been limited’ [27] or feel that they are ‘shouldering an undue
burden to follow strict isolation policies, as healthcare workers
[HCW]… are not subject to MRSA testing’ [44]. Others question the
‘required openness’ that is demanded, considering ‘the potential
colonization among HCWs’ [33].
HCWs further complicate the situation: carriers receive mixed
messages or information that is incorrect [31,33,40,45]. ‘Staff-
members encouraged them to apply good hand-hygiene while staff
themselves do not follow this routine’ [45]. Indeed, some feel
confused about why some staff do not need to follow strict isolation
policies or why isolation policies are not required in the community
[20,44]. Protective clothing is described as ‘being ready for a trip to
outer space’ [33].
Fig. 1. Flowchart search strategy.
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Affiliation (capability 7)
The capability ‘affiliation’ reflects the opportunities one has to
affiliation and social interaction. The studies elaborate extensively
on negative consequences that are relevant for this capability (18 of
27 studies in total) (Loveday H et al., ‘The patient experience of the
MRSA screening process’; Mo Y, Tambyah PA, ‘Socioeconomic
impact of multiresistant nosocomial infections’)
[20,23,25,27e33,36e40,44,45]. This includes capability 7A (the
space available for living with and towards others) as well as 7B
(self-respect and nonhumiliation) in normal social interaction
(7b1) and specifically within healthcare (7B2).
Firstly, carriage has negative consequences for physical and
mental interaction with loved ones (7A; 12 studies)
[20,23,25,27,31e33,37,38,40,44,45]. Carriers fear that they may
harm their surroundings [20,23,33,38,44]. Some mention ‘an
intense fear of being a danger to their children and grandchildren’
[20] and ‘a fear that their children would be noted as the one with
the contagion’ [31]. Some carriers do not want their relatives to
worry and therefore refrain from informing them about the
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aPaper presentations by Mo et al. and/or Loveday et al. are included in the study count 
Fig. 2. Narrative figure.
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situation [45]. Others isolate themselves and their family in order to
prevent stigma [31,33]. Hospital isolation measures can negatively
affect the emotional interaction with loved ones [25,27,28,44], but
these isolation measures may also have positive effects [27,37]. One
study observes no worries for carriers and relatives [25].
Secondly, carriage has a negative impact on self-respect (7B1, 16
studies) (Loveday H et al., ‘The patient experience of the MRSA
screening process’; Mo Y, Tambyah PA, ‘Socioeconomic impact
of multiresistant nosocomial infections’) [20,25,27e29,31e33,36,
38e40,44,45]. Studies by Lindberg and colleagues [31,33],
Wiklund et al. [45] and Skyman et al. [40] assess the impact of
carriage on normal social interaction and show how carriers feel
stigmatized. This is not only a matter of perception; actual social
situations in which carriers are treated differently are described
[31,33]. Some seem to internalize this stigma. They can be upset for
generating fear in their surroundings, and they have strong con-
cerns over being a danger to others (Loveday H et al., ‘The patient
experience of the MRSA screening process’) [20,27,33]. The situa-
tion comes with a feeling of being dirty and unclean, and hygiene
becomes of particular concern for carriers [20,31e33,44,45]. Some
actually change their behaviour, such as increasing sanitation or
hand hygiene [20,32,33,45]. Some also report the absence of stigma
or a ‘commitment to protecting others’ (Mo Y, Tambyah PA, ‘So-
cioeconomic impact of multiresistant nosocomial infections’) [33].
Hesitation about disclosure of one's AMR status is also reported
[31,33,38,44].
Carriage seemed especially problematic for social interaction
within healthcare (Extra category 7B2 ‘in healthcare,’ 13 studies)
(Mo Y, Tambyah PA, ‘Socioeconomic impact of multiresistant
nosocomial infections’) [20,25,27,28,30,31,33,36,39,40,44,45].
HCWs are reported to act unknowingly and uncaringly, and carriers
feel they cannot question such behaviour (Mo Y, Tambyah PA, ‘So-
cioeconomic impact of multiresistant nosocomial infections’)
[20,31,39,45]. The interaction is described as being ‘met with
disrespect and humiliation’ [39]; ‘at the mercy of healthcare’ [45];
‘treated like a plague victim’ [27,31,40,45]. Further, infection is seen
as part of one's identity [31] and as being ‘exposed to other people's
shortcomings' [20]. HCWs are perceived as unfriendly [28] and as
sloppy and neglecting [28,31], and carriers are twice as likely to
express greater dissatisfaction, reflected in informal and formal
complaints [39]. Carriers perceive anMRSA door sign as ‘a breach in
confidentiality’ [36]. Studies also show good experiences: some
report that friendly staff is very important to them [28], some are
satisfied when visits are prepared and continuity is achieved [33]
and Giese et al. [25] finds only a minority reporting negative
impact on interaction with staff.
Being able to laugh, play and to enjoy recreational activities
(capability 9)
Carriage sets limitations to the ability to engage in recreational
activities (seven of 27 studies) [20,32,33,36,40,44,45]. Carriers have
questions about going to the hairdresser, going shopping, having a
cup of tea with friends or using public facilities (public transport,
communal shower rooms) [20,33,40,45]. Some feel that ‘they are
not able to live a normal life or that they adapt their needs to MRSA
in order to live a normal life,’ while others live their life as usual
[33]. Isolation is perceived as boring [36,44]. Some feel ‘that MRSA
did not affect their lives, they [say] that because they neither see or
feel the bacteria they forget about it’ [33].
Having control over one's environments (capability 10b)
This capability reflects the people's material and political secu-
rity and the opportunities they have to influence their environment
(four studies) (Mo Y, Tambyah PA, ‘Socioeconomic impact of multi-
resistant nosocomial infections’) [20,33,45]. Carriage can have a
significant financial impact (Mo Y, Tambyah PA, ‘Socioeconomic
impact of multiresistant nosocomial infections’). It creates in-
securities about job opportunities, especially for HCWs [20,33,45].
Someonedescribes how ‘herwhole futurewas affected because [. . . ]
there were jobs that she was not permitted to do,’ and another
participantdescribes the situation as ‘something that is good’ and ‘as
a new start’ [20].
Discussion
This review shows that MDRO carriage and related control
measures can have negative implications for six out of ten capa-
bilities, thus visualizing an array of unintended consequences, even
though some carriers also appreciate certain aspects, notably
increased privacy [24,29,33,36,37,40]. Most included studies con-
cerned MRSA, which is not surprising: MRSA has been around the
longest and requires strict isolationdin contrast to, for example,
multidrug-resistant Gram-negative bacteria, for which precaution
measures are often less stringent [3e5].
An important finding is that carriers have a limited under-
standing of the implications of the control measures for their per-
sonal situation and how to relate these to the overall problem of
AMR. This affects their sense of control. Healthcare providers
should thus dedicate time to explain what is at stake and listen to
and acknowledge the questions, uncertainties, fears and desires of
carriers onwhom control measures are imposed. Such dedication is
also necessary to prevent the stigma that carriers experience,
specifically within healthcare practice [46]. Control measures easily
isolate patients from their social environment, and healthcare in-
stitutions should minimize these effects. Similarly, involvement of
family and friends can further reduce stigma and other negative
experiences.
Our findings suggest that many HCWs also struggle with un-
derstanding AMR and its implications for patient care. AMR is a
notoriously complex problem, creating ethical dilemmas [47,48].
More research is needed to better understand this lack of full
comprehension and to address this (ethical) complexity. This per-
mits honesty towards carriers, but it may also be essential for
acceptance of AMR control measures in the future.
Transparency declaration
Financial support was received from the Ministry of Health,
Welfare and Sport, the Netherlands (V/150013/18/ED), and the
Netherlands Organisation for Health Research and Development
(ZonMw/731010011). All authors report no conflicts of interest
relevant to this review.
Acknowledgement
We thank R. Deurenberg for helpwith building the bibliographic
search strategy and the optimization of this strategy for each
database.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.cmi.2018.10.007.
References
[1] Centers for Disease Control and Prevention; US Departement of Health and
Human Services. Antibiotic resistance threats in the United States. CDC report.
B. Rump et al. / Clinical Microbiology and Infection 25 (2019) 274e279278
2013. Available at: https://www.cdc.gov/drugresistance/threat-report-2013/
pdf/ar-threats-2013-508.pdf.
[2] European Centers for Disease Prevention and Control; European Medicine
Agency. The bacterial challenge: time to react. 2009. Available at: https://ecdc.
europa.eu/sites/portal/files/media/en/publications/Publications/0909_TER_
The_Bacterial_Challenge_Time_to_React.pdf.
[3] Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for pre-
venting nosocomial transmission of highly resistant microorganisms (HRMO).
Infection 2005;33:309e13.
[4] Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation
precautions: preventing transmission of infectious agents in health care set-
tings. Am J Infect Control 2007;35:S65e164.
[5] Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-
resistant organisms in health care settings, 2006. Am J Infect Control
2007;35:S165e93.
[6] Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised pa-
tients: a systematic review. J Hosp Infect 2010;76:97e102.
[7] Barratt RL, Shaban R, Moyle W. Patient experience of source isolation: lessons
for clinical practice. Contemp Nurse 2011;39:180e93.
[8] Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes
associated with Contact Precautions: a review of the literature. Am J Infect
Control 2009;37:85e93.
[9] Mutsonziwa GA, Green J. Colonised and isolated: a qualitative metasynthesis
of patients’ experiences of being infected with multiple drug resistant or-
ganisms and subsequent isolation. Healthc Infect 2011;16:147e55.
[10] Stanford Encyclopedia of Philosophy Archive. The capability approach. 2016.
Available at: https://plato.stanford.edu/archives/win2016/entries/capability-
approach/.
[11] Sen A. Equality of what?. In: McMurrin S, editor. Tanner lectures on human
values, volume 1. Cambridge: Cambridge University Press; 1980. p. 199e220.
[12] Nussbaum MC. Defense of universal values. In: Nussbaum MC, editor. Women
and human development. Cambridge: Cambridge University Press; 2000.
p. 24e110.
[13] Entwistle VA, Watt IS. Treating patients as persons: a capabilities approach to
support delivery of person-centered care. Am J Bioeth 2013;13. gleeson-39.
[14] Venkatapuram S. Health, vital goals, and central human capabilities. Bioethics
2013;27:271e9.
[15] Mitchell PM, Roberts TE, Barton PM, Coast J. Applications of the capability
approach in the health field: a literature review. Soc Indicators Res 2017;133:
345e71.
[16] Millar MR. A capabilities perspective on healthcare associated infection. Am J
Bioeth 2013;13:53e4.
[17] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for sys-
tematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol
2009;62:1006e12.
[18] Whittemore R, Knafl K. The integrative review: updated methodology. J Adv
Nurs 2005;52:546e53.
[19] Pluye P, Hong QN. Combining the power of stories and the power of numbers:
mixed methods research and mixed studies reviews. Annu Rev Public Health
2014;35. gleeson-45.
[20] Andersson H, Lindholm C, Fossum B. MRSA-global threat and personal
disaster: patients’ experiences. Int Nurs Rev 2011;58:47e53.
[21] Catalano G, Houston SH, Catalano MC, Butera AS, Jennings SM, Hakala SM,
et al. Anxiety and depression in hospitalized patients in resistant organism
isolation. South Med J 2003;96:141e5.
[22] Day HR, Perencevich EN, Harris AD, Himelhoch SS, Brown CH, Gruber-
Baldini AL, et al. Do contact precautions cause depression? A two-year study
at a tertiary care medical centre. J Hosp Infect 2011;79:103e7.
[23] Donaldson AD, Jalaludin BB, Chan RC. Patient perceptions of osteomyelitis,
septic arthritis and prosthetic joint infection: the psychological influence of
methicillin-resistant Staphylococcus aureus. Intern Med J 2007;37:536e42.
[24] Evans HL, Shaffer MM, Hughes MG, Smith RL, Chong TW, Raymond DP, et al.
Contact isolation in surgical patients: a barrier to care? Surgery 2003;134:
180e8.
[25] Giese A, Bous J, Werner S, Lemm F, Wilhelm M, Henning BF. Postponing
elective hospitalizations for pre-admission MRSA screening and
decolonization. A study evaluating eligibility and acceptance among patients
of a German university hospital. Int J Hyg Environ Health 2013;216:126e31.
[26] Gleeson A, Larkin P. The impact of an MRSA diagnosis on patients in the
specialist palliative care setting. Psychooncology 2010;19:S220.
[27] Goldsack JC, DeRitter C, Power M, Spencer A, Taylor CL, Kim SF, et al. Clinical,
patient experience and cost impacts of performing active surveillance on
known methicillin-resistant Staphylococcus aureus positive patients admitted
to medical-surgical units. Am J Infect Control 2014;42:1039e43.
[28] Hartmann C. How patients experience an isolation in a hospital due to
infection or colonisation with MRSA [in German]. Hyg Med 2005;30:234e43.
[29] Kennedy P, Hamilton LR. Psychological impact of the management of
methicillin-resistant Staphylococcus aureus (MRSA) in patients with spinal
cord injury. Spinal Cord 1997;35:617e9.
[30] Levitt GA. Infection control for MRSA in a psychiatric hospital. Gen Hosp
Psychiatry 2014;36:422e4.
[31] Lindberg M, Carlsson M, Skytt B. MRSA-colonized persons’ and healthcare
personnel’s experiences of patienteprofessional interactions in and re-
sponsibilities for infection prevention in Sweden. J Infect Public Health
2014;7:427e35.
[32] Briggs JJ, Milstone AM. Changes over time in caregivers’ knowledge, attitudes,
and behaviors regarding methicillin-resistant Staphylococcus aureus. J Pediatr
2011;158:1039.
[33] Lindberg M, Carlsson M, Hogman M, Skytt B. Suffering from meticillin-
resistant Staphylococcus aureus: experiences and understandings of coloni-
sation. J Hosp Infect 2009;73:271e7.
[34] Livorsi DJ, Kundu MG, Batteiger B, Kressel AB. Effect of contact precautions for
MRSA on patient satisfaction scores. J Hosp Infect 2015;90:263e6.
[35] Loeb M, Moss L, Stiller A, Smith S, Russo R, Molloy DW, et al. Colonization with
multiresistant bacteria and quality of life in residents of long-term-care fa-
cilities. Infect Control Hosp Epidemiol 2001;22:67e8.
[36] Madeo M. Understanding the MRSA experience. Nurs Times 2001;97:36e7.
[37] Newton JT, Constable D, Senior V. Patients’ perceptions of methicillin-resistant
Staphylococcus aureus and source isolation: a qualitative analysis of source-
isolated patients. J Hosp Infect 2001;48:275e80.
[38] Sengupta A, Rand C, Perl TM, Milstone AM. Knowledge, awareness, and atti-
tudes regarding methicillin-resistant Staphylococcus aureus among caregivers
of hospitalized children. J Pediatr 2011;158:416e21.
[39] Skyman E, Bergbom I, Lindahl B, Larsson L, Lindqvist A, Sj€ostr€om HT, et al.
Notification card to alert for methicillin-resistant Staphylococcus aureus is
stigmatizing from the patient’s point of view. Scand J Infect Dis 2014;46:
440e6.
[40] Skyman E, Sjostrom HT, Hellstrom L. Patients experiences of being infected
with MRSA at a hospital and subsequently source isolated. Scnd J Caring Sci
2010;24:101e7.
[41] Soon MM, Madigan E, Jones KR, Salata RA. An exploration of the psychologic
impact of contact isolation on patients in Singapore. Am J Infect Control
2013;41:e111e3.
[42] Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection
control. JAMA 2003;290:1899e905.
[43] Tarzi S, Kennedy P, Stone S, Evans M. Methicillin-resistant Staphylococcus
aureus: psychological impact of hospitalization and isolation in an older adult
population. J Hosp Infect 2001;49:250e4.
[44] Webber KL, Macpherson S, Meagher A, Hutchinson S, Lewis B. The impact of
strict isolation on MRSA positive patients: an action-based study undertaken
in a rehabilitation center. Rehabil Nurs 2012;37:43e50.
[45] Wiklund S, Hallberg U, Kahlmeter G, Tammelin A. Living with extended-
spectrum beta-lactamase: a qualitative study of patient experiences. Am J
Infect Control 2013;41:723e7.
[46] Weiss MG, Ramakrishna J, Somma D. Health-related stigma: rethinking con-
cepts and interventions. Psychol Health Med 2006;11:277e87.
[47] Littmann J. Antimicrobial resistance and distributive justice. Unpublished
doctoral dissertation, University College London; 2014.
[48] Rump B, Timen A, Hulscher M, Verweij M. Ethics of infection control measures
for carriers of antimicrobial drugeresistant organisms. Emerg Infect Dis
2018;24:1609e16. https://doi.org/10.3201/eid2409.171644.
B. Rump et al. / Clinical Microbiology and Infection 25 (2019) 274e279 279
